Advanced Cell Technology, Inc. is a biotechnology company that develops human embryonic and adult stem cell technology. The company has ownership/licensing of approximately 37 patents and approximately 190 patent applications pending in the regenerative medicine and stem cell therapy fields. … Continue reading →

Alcobra Ltd. is an emerging biopharmaceutical company that develops and markets drugs for the treatment of central nervous system disorders and cognitive dysfunctions. The company is primarily focused on developing and marketing its most advanced drug, MG01CI, a non-stimulant attention … Continue reading →

Champions Oncology, Inc. offers technology solutions that personalize the development and use of oncology drugs. The company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Through this platform, … Continue reading →

Spectrum Pharmaceuticals, Inc. is a biotechnology company engaged in acquiring, developing, and marketing prescription drug products for hematology and oncology. The company’s oncology products include FUSILEV for patients with osteosarcoma after high-dose methotrexate therapy; FOLOTYN, a folate analogue metabolic inhibitor … Continue reading →

OncoSec Medical Incorporated (ONCS) OncoSec Medical Incorporated (OTC: ONCS) designs and develops novel cancer therapeutic products. The company’s products combine proprietary delivery technology with a novel DNA-based immunotherapeutics, known as OMS ElectroOncology. Its clinical programs include The NeoPulse approach, which … Continue reading →

Heat Biologics, Inc. is a biopharmaceutical company developing cellular therapeutic vaccines for cancers and infectious diseases. The company is developing the Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are reprogrammed to pump out various … Continue reading →

NeoStem, Inc. develops proprietary cell therapy products. It is involved in: manufacturing cell therapy-based products; product and process development; cell and tissue processing; regulatory support, storage, distribution and delivery; and consulting services. The company also provides contract development and manufacturing … Continue reading →

Inovio Pharmaceuticals, Inc. (NYSE: INO) and its subsidiaries engage in discovering and developing synthetic vaccines and immune therapies for cancers and other infectious diseases. Inovio’s DNA-based SynCon technology facilitates the design of vaccines capable of providing cross-protection against new, unmatched … Continue reading →

Kips Bay Medical, Inc. (NASDAQ: KIPS) is a medical device company that manufactures its external saphenous vein support technology (eSVS Mesh) for use in coronary artery bypass grafting (CABG) surgery. Its eSVS Mesh is a flexible, semi-compliant, kink-resistant, tubular-shaped device … Continue reading →

Fluoropharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FPMI’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents … Continue reading →